Physician profile
Iram Hamdard
NPI 1730164252
$1,658.80
in general payments reported to CMS, 2019-2025
22 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $58.44 · 2021: $375 · 2022: $269 · 2023: $71.87 · 2024: $194 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $325.80 | 2019-2023 | Otezla, Repatha |
| Indivior INC. | $198.51 | 2019-2021 | |
| Lilly USA, LLC | $169.29 | 2019-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $134.92 | 2021-2024 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Abbvie INC. | $96.41 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $89.54 | 2019-2025 | Farxiga, Airsupra |
| Novo Nordisk INC | $81.63 | 2019-2025 | Rybelsus, Ozempic |
| Dexcom, INC. | $58.07 | 2024-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $57.31 | 2021 | |
| Allergan, INC. | $47.18 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.80 | 2021-2022 | |
| Orexo US, INC. | $26.94 | 2021-2023 | Zubsolv |
| Janssen Pharmaceuticals, INC | $26.36 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $25.41 | 2021 | |
| Glaxosmithkline, LLC. | $24.88 | 2024 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $24.30 | 2019-2020 | |
| Amarin Pharma, INC. | $21.35 | 2021 | |
| Exact Sciences Corporation | $18.39 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $17.64 | 2022 | |
| Astellas Pharma US INC | $16.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iram Hamdard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.